Search Within

Jeffrey Yuan

Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Department of Medicine (5)
  2. Solid Tumor Oncology Division (4)
  3. Biostatistics Service (3)
  4. Breast Medicine Service (3)
  5. Epidemiology and Biostatistics (3)
  6. GSK Faculty (3)

More Groups

People
  1. Clifford Hudis (3)
  2. Gabriella D'Andrea-Carlino (3)
  3. Sujata Patil (3)
  4. Andrew Seidman (2)
  5. Larry Norton (2)
  6. Monica Fornier (2)

More People

Years
  1. 2010 (1)
  2. 2009 (4)
Publications
  1. Journal of Clinical Oncology (2)
  2. Annals of Oncology (1)
  3. Clinical Breast Cancer (1)
  4. Journal of Investigative Dermatology (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Elsevier Inc. (1)
  3. Elsevier Science, Inc. (1)
  4. Oxford University Press (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancer
    Journal Article

    Drullinsky, P.; Sugarman, S. M.; Fornier, M. N.; D'Andrea, G.; Gilewski, T.; Lake, D.; Traina, T.; Wasserheit-Lieblich, C.; Sklarin, N.; Atieh-Graham, D.; more...
    Clinical Breast Cancer (2010)

    Fulltext@MSK | Save
  • Cytokine changes in castrate metastatic prostate cancer (CPMC) patients (pts) treated with ipilimumab (Ipi)
    Meeting Abstract

    Yuan, J.; Orlandi, F.; Jefferson, M.; Li, H.; Gallardo, H.; Ku, G.; Wolchok, J.; Scher, H.; Allison, J.; Slovin, S. F.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Dose-dense (DD) cyclophosphamide, methotrexate, and fluorouracil (CMF) at 14-day intervals: A pilot study of every 14- and 10-11-day dosing intervals for women with early-stage breast cancer
    Meeting Abstract

    Drullinsky, P.; Fornier, M. N.; Sugarman, S.; D'Andrea, G.; Troso-Sandoval, T.; Seidman, A. D.; Yuan, J.; Patil, S.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Androgen receptor inhibition can stabilize disease in patients with AR(+), ER(-)/PR(-) metastatic breast cancer
    Meeting Abstract

    Traina, T. A.; Feigin, K.; Patil, S.; Yuan, J.; Dickler, M.; Andrea, G. D.; Bromberg, J.; Hudis, C.
    Annals of Oncology (2009)

    Fulltext@MSK | Save
  • Myxoma virus and heat-treated vaccinia induce type I interferon and TNF-alpha in human plasmacytoid dendritic cells through an endosomal TLR-mediated, PI3K/AKT-dependent signaling pathway
    Meeting Abstract

    Cao, H.; Dai, P.; Li, H.; Yuan, J.; Young, J. W.; Condit, R.; McFadden, G.; Shuman, S.; Deng, L.
    Journal of Investigative Dermatology (2009)

    Fulltext@MSK | Save